Please provide your email address to receive an email when new articles are posted on . Fewer people with diabetes filled glucagon prescriptions in 2021 compared with 2011, though increases were seen ...

Michael Weiss and his fellow researchers have made significant progress in identifying a new type of medication that can regulate both insulin and glucagon in Type 1 diabetes patients. INDIANAPOLIS — ...

Reducing injection burden has long been a priority in diabetes care. Now, a weekly, fixed-dose combination of basal insulin and a GLP-1 receptor agonist is one step closer to approval in Europe.

Mounjaro is a new medication used to manage blood sugar levels in people who have type 2 diabetes. This medication offers weight loss and cardiovascular benefits, which can also help with insulin ...

* A lab-designed protein mimicking both insulin and glucagon has shown promising results for controlling blood sugar in Type 1 diabetes * The formulation may not require refrigeration, making ...

An innovative ‘smart insulin’ may offer people living with type 1 diabetes improved treatment options to regulate blood glucose levels. This is the discovery of researchers at Indiana University, who ...

Indianapolis-based pharma giant Eli Lilly has announced the company now offers an Android version of its app, called Glucagon, which is designed to help caregivers and providers treat people with ...

New findings raise the possibility of promising therapeutic strategies for the management of hypoglycemia in type 1 diabetes patients. Study: Loss of electrical β-cell to δ-cell coupling underlies ...

If you have type 2 diabetes, it’s important to manage your hormone levels, as an imbalance can alter how your body responds to insulin. Lifestyle measures like reducing stressors and eating a balanced ...

Beta cells play a key role in the pathogenesis of both Type 1 and Type 2 diabetes. However, pancreatic islets also have alpha cells that produce the hormone glucagon, which acts to raise glucose blood ...